On the public citation graph

GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type

0 signed · 488 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.cd001750.pub4openalex-snapshot

Gonadotrophin-releasing hormone antagonists for assisted reproductive technology

inferredcites →https://doi.org/10.1002/14651858.cd006109.pub2openalex-snapshot

Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques

inferredcites →https://doi.org/10.1002/14651858.cd006109.pub3openalex-snapshot

Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques

inferredcites →https://doi.org/10.1002/14651858.cd008046.pub4openalex-snapshot

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology

inferredcites →https://doi.org/10.1007/s00404-008-0620-9openalex-snapshot

Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial

inferredcites →https://doi.org/10.1007/s00404-009-1073-5openalex-snapshot

Comparing GnRH agonist long protocol and gnrh antagonist protocol in outcome the first cycle of ART

inferredcites →https://doi.org/10.1007/s00404-009-1252-4openalex-snapshot

Comparison of mild stimulation and conventional stimulation in ART outcome

inferredcites →https://doi.org/10.1007/s00404-010-1429-xopenalex-snapshot

Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients

inferredcites →https://doi.org/10.1007/s00404-012-2348-9openalex-snapshot

IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial

inferredcites →https://doi.org/10.1007/s00404-012-2522-0openalex-snapshot

A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients

inferredcites →https://doi.org/10.1007/s10815-006-9036-2openalex-snapshot

Efficacy of Low-Dose Human Chorionic Gonadotropin (hCG) in a GnRH Antagonist Protocol

inferredcites →https://doi.org/10.1007/s10815-008-9249-7openalex-snapshot

Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study

inferredcites →https://doi.org/10.1007/s10815-009-9300-3openalex-snapshot

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study

inferredcites →https://doi.org/10.1007/s10815-014-0227-yopenalex-snapshot

“Mild” vs. “long” protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial

inferredcites →https://doi.org/10.1007/s12325-008-0028-8openalex-snapshot

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients

inferredcites →https://doi.org/10.1016/j.ejogrb.2004.11.005openalex-snapshot

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy

inferredcites →https://doi.org/10.1016/j.ejogrb.2005.08.017openalex-snapshot

Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles

inferredcites →https://doi.org/10.1016/j.ejogrb.2012.09.008openalex-snapshot

GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial

inferredcites →https://doi.org/10.1016/j.ejogrb.2014.12.021openalex-snapshot

GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial

inferredcites →https://doi.org/10.1016/j.fertnstert.2004.04.051openalex-snapshot

A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol

inferredcites →https://doi.org/10.1016/j.fertnstert.2004.06.076openalex-snapshot

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization

inferredcites →https://doi.org/10.1016/j.fertnstert.2004.12.037openalex-snapshot

Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration

inferredcites →https://doi.org/10.1016/j.fertnstert.2006.02.110openalex-snapshot

Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial

inferredcites →https://doi.org/10.1016/j.fertnstert.2006.12.046openalex-snapshot

GnRH agonist and antagonist protocols for stage I–II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles

inferredcites →https://doi.org/10.1016/j.fertnstert.2007.02.002openalex-snapshot

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

inferredcites →https://doi.org/10.1016/j.fertnstert.2007.04.006openalex-snapshot

The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study

inferredcites →https://doi.org/10.1016/j.fertnstert.2008.02.165openalex-snapshot

Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40

inferredcites →https://doi.org/10.1016/j.fertnstert.2009.05.013openalex-snapshot

Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection

inferredcites →https://doi.org/10.1016/j.fertnstert.2010.02.059openalex-snapshot

Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors

inferredcites →https://doi.org/10.1016/j.fertnstert.2010.05.052openalex-snapshot

Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial

inferredcites →https://doi.org/10.1016/j.fertnstert.2011.01.134openalex-snapshot

A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders

inferredcites →https://doi.org/10.1016/j.fertnstert.2011.06.022openalex-snapshot

Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial

inferredcites →https://doi.org/10.1016/j.fertnstert.2013.09.035openalex-snapshot

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

inferredcites →https://doi.org/10.1016/j.fertnstert.2014.03.047openalex-snapshot

Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper

inferredcites →https://doi.org/10.1016/j.gyobfe.2009.04.028openalex-snapshot

Efficacité de la programmation des cycles FIV en antagonistes par les estrogènes

inferredcites →https://doi.org/10.1016/s0015-0282(00)01638-1openalex-snapshot

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

inferredcites →https://doi.org/10.1016/s0015-0282(99)00524-5openalex-snapshot

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)

inferredcites →https://doi.org/10.1016/s0140-6736(01)06797-6openalex-snapshot

Gonadotropin-releasing-hormone-receptor antagonists

inferredcites →https://doi.org/10.1016/s0140-6736(07)60360-2openalex-snapshot

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial

inferredcites →https://doi.org/10.1016/s1028-4559(08)60057-1openalex-snapshot

Comparisons of Different Dosages of Gonadotropin-Releasing Hormone (GnRH) Antagonist, Short-acting Form and Single, Half-dose, Long-acting Form of GnRH Agonist During Controlled Ovarian Hyperstimulation and in vitro Fertilization

inferredcites →https://doi.org/10.1016/s1472-6483(10)60420-8openalex-snapshot

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS

inferredcites →https://doi.org/10.1016/s1472-6483(10)60957-1openalex-snapshot

GnRH antagonist in IVF poor-responder patients: results of a randomized trial

inferredcites →https://doi.org/10.1016/s1472-6483(10)60976-5openalex-snapshot

Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study

inferredcites →https://doi.org/10.1016/s1472-6483(10)61059-0openalex-snapshot

Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane Review

inferredcites →https://doi.org/10.1016/s1472-6483(10)61631-8openalex-snapshot

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

inferredcites →https://doi.org/10.1016/s1472-6483(10)61661-6openalex-snapshot

Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol

inferredcites →https://doi.org/10.1016/s1472-6483(10)61868-8openalex-snapshot

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles – a prospective, randomized study

inferredcites →https://doi.org/10.1080/09513590600702733openalex-snapshot

Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol – a randomized study

inferredcites →https://doi.org/10.1080/09513590801893331openalex-snapshot

Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients

inferredcites →https://doi.org/10.1080/09513590802617762openalex-snapshot

Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols forin vitrofertilisation and embryo transfer

inferredcites →https://doi.org/10.1093/humrep/13.11.3023openalex-snapshot

A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The…

inferredcites →https://doi.org/10.1093/humrep/15.11.2333openalex-snapshot

Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study

inferredcites →https://doi.org/10.1093/humrep/15.3.526openalex-snapshot

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

inferredcites →https://doi.org/10.1093/humrep/15.7.1490openalex-snapshot

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

inferredcites →https://doi.org/10.1093/humrep/16.4.644openalex-snapshot

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

inferredcites →https://doi.org/10.1093/humrep/deh357openalex-snapshot

Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels

inferredcites →https://doi.org/10.1093/humrep/deh375openalex-snapshot

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study

inferredcites →https://doi.org/10.1093/humrep/deh668openalex-snapshot

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

inferredcites →https://doi.org/10.1093/humrep/deh832openalex-snapshot

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

inferredcites →https://doi.org/10.1093/humrep/dei243openalex-snapshot

Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles

inferredcites →https://doi.org/10.1093/humrep/dei302openalex-snapshot

A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients

inferredcites →https://doi.org/10.1093/humrep/del030openalex-snapshot

Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study

inferredcites →https://doi.org/10.1093/humrep/del484openalex-snapshot

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

inferredcites →https://doi.org/10.1093/humrep/dem033openalex-snapshot

Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development

inferredcites →https://doi.org/10.1093/humrep/dem204openalex-snapshot

Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy

inferredcites →https://doi.org/10.1093/humrep/dem270openalex-snapshot

Are GnRH antagonists comparable to agonists for use in IVF?

inferredcites →https://doi.org/10.1093/humrep/dep436openalex-snapshot

Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)

inferredcites →https://doi.org/10.1093/humrep/des066openalex-snapshot

GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study

inferredcites →https://doi.org/10.1093/humrep/dew051openalex-snapshot

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles

inferredcites →https://doi.org/10.1093/humupd/dml001openalex-snapshot

GnRH antagonists in ovarian stimulation for IVF

inferredcites →https://doi.org/10.1093/humupd/dml038openalex-snapshot

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

inferredcites →https://doi.org/10.1093/oxfordjournals.humrep.a138123openalex-snapshot

The effects of a gonadotrophin-releasing hormone agonist on treatment with low dose follicle stimulating hormone in polycystic ovary syndrome

inferredcites →https://doi.org/10.1111/j.1447-0756.2010.01247.xopenalex-snapshot

Comparison of gonadotropin‐releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients

inferredcites →https://doi.org/10.1159/000362274openalex-snapshot

Patients' Preferences for Gonadotrophin-Releasing Hormone Analogs in in vitro Fertilization

inferredcites →https://doi.org/10.1186/1477-7827-10-33openalex-snapshot

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

inferredcites →https://doi.org/10.1210/jc.2002-020788openalex-snapshot

A Randomized Comparison of Two Ovarian Stimulation Protocols with Gonadotropin-Releasing Hormone (GnRH) Antagonist Cotreatment forin VitroFertilization Commencing Recombinant Follicle-Stimulating Hormone on Cycle Day 2 or 5 with the Standard Long GnRH Agonist Protocol

inferredcites →https://doi.org/10.1210/jc.2003-031766openalex-snapshot

Induction of Multiple Follicular Development by a Single Dose of Long-Acting Recombinant Follicle-Stimulating Hormone (FSH-CTP, Corifollitropin Alfa) for Controlled Ovarian Stimulation beforein VitroFertilization

inferredcites →https://doi.org/10.1371/journal.pone.0106854openalex-snapshot

Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis

inferredcites →https://doi.org/10.2165/00003495-200464030-00005openalex-snapshot

Contemporary Pharmacological Manipulation in Assisted Reproduction

inferredcites →https://doi.org/10.3109/09513590.2012.665103openalex-snapshot

A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates

inferredcites →https://doi.org/10.5653/cerm.2011.38.4.228openalex-snapshot

GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI

inferredcites →https://doi.org/10.5653/cerm.2012.39.1.22openalex-snapshot

Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI

inferredcites →https://doi.org/10.5653/cerm.2012.39.4.166openalex-snapshot

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome:In vitromaturation, GnRH agonist, and GnRH antagonist cycles

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4093743openalex-extracted

Obese Patients May Benefit from GnRH-A Long Protocol Due to Higher Implantation Rate and Live Birth Rate of IVF-ET

inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2026.29406openalex-snapshot

A Telemedicine-Supported Home-Injection Model for Patients With Breast Cancer

inferred← citeshttps://doi.org/10.1002/14651858.cd012586.pub2openalex-snapshot

Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis

inferred← citeshttps://doi.org/10.1002/9781119622215.ch105openalex-snapshot

Managing physical symptoms during IVF

inferred← citeshttps://doi.org/10.1002/9781119622215.ch45openalex-snapshot

Poor response during ovarian stimulation

inferred← citeshttps://doi.org/10.1002/9781119622215.ch46openalex-snapshot

Ovarian stimulation for IVF in a patient at high risk of ovarian hyperstimulation syndrome

inferred← citeshttps://doi.org/10.1002/9781119622215.ch52openalex-snapshot

The patient over‐responding to controlled ovarian stimulation during IVF

inferred← citeshttps://doi.org/10.1002/9781119622215.ch54openalex-snapshot

Delayed oocyte retrieval

inferred← citeshttps://doi.org/10.1002/9781119622215.ch70openalex-snapshot

The patient presenting with ovarian hyperstimulation syndrome

inferred← citeshttps://doi.org/10.1002/cam4.7034openalex-snapshot

Fertility counselling and fertility preservation among early onset female cancer patients—A Finnish register‐based study

inferred← citeshttps://doi.org/10.1002/chir.23552openalex-snapshot

Evaluation of effects of temperature and humidity on the secondary structure of Ganirelix in an injectable formulation and comparison with Orgalutran® using circular dichroism spectroscopy

inferred← citeshttps://doi.org/10.1002/cpt.70136openalex-snapshot

Real‐World Effectiveness and Safety of Recombinant Human Follicle‐Stimulating Hormone (rhFSH) in Infertile Women undergoing Assisted Reproductive Technology (ART): A Korean Nationwide Cohort Study

inferred← citeshttps://doi.org/10.1002/ijgo.13626openalex-snapshot

Comparison of in vitro fertilization cycles stimulated with 20 mg letrozole daily versus high‐dose gonadotropins in Rotterdam Consensus ultra‐poor responders: A proof of concept

inferred← citeshttps://doi.org/10.1002/rmb2.12424openalex-snapshot

A novel orally active gonadotropin‐releasing hormone antagonist, relugolix, is a potential substitute for injectable GnRH antagonists in controlled ovarian stimulation in assisted reproductive technology

inferred← citeshttps://doi.org/10.1002/rmb2.12429openalex-snapshot

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS

inferred← citeshttps://doi.org/10.1002/rmb2.12573openalex-snapshot

Efficacy and safety of follitropin delta versus follitropin alpha/beta in infertility treatment: A systematic review and meta‐analysis

inferred← citeshttps://doi.org/10.1007/978-3-030-63650-0_9openalex-snapshot

Infertility Management in Lean Versus Obese PCOS

inferred← citeshttps://doi.org/10.1007/978-3-030-99596-6_17openalex-snapshot

Assisted Reproductive Technology: Clinical Aspects

inferred← citeshttps://doi.org/10.1007/978-3-031-77255-9_14openalex-snapshot

The Management of IVF Patients with Diminished Ovarian Reserve

inferred← citeshttps://doi.org/10.1007/978-3-031-77255-9_5openalex-snapshot

GnRH Antagonists and GnRH Agonists in Assisted Reproduction

inferred← citeshttps://doi.org/10.1007/978-3-031-77255-9_6openalex-snapshot

IVF Protocols: Past, Present, and Future

inferred← citeshttps://doi.org/10.1007/978-3-662-65371-5_14openalex-snapshot

Ovarielle Stimulation, Ovulationsinduktion und Lutealphasenunterstützung

inferred← citeshttps://doi.org/10.1007/978-981-15-2377-9_37openalex-snapshot

Ovarian Hyperstimulation Syndrome

inferred← citeshttps://doi.org/10.1007/978-981-33-4187-6_1openalex-snapshot

Introduction to Environmental Harmful Factors

inferred← citeshttps://doi.org/10.1007/978-981-95-1373-4_6openalex-snapshot

Ultrasound Assessment of Endometrial Receptivity

inferred← citeshttps://doi.org/10.1007/s00129-018-4290-9openalex-snapshot

Assistierte Reproduktion: Möglichkeiten und Grenzen

inferred← citeshttps://doi.org/10.1007/s00129-023-05150-5openalex-snapshot

Schwanger werden nach Krebs – Chancen, Risiken und Unterstützungsmöglichkeiten?

inferred← citeshttps://doi.org/10.1007/s00129-024-05280-4openalex-snapshot

Orale GnRH-Antagonisten in der kontrollierten ovariellen Stimulation: noch viele Fragen offen

inferred← citeshttps://doi.org/10.1007/s00129-025-05390-7openalex-snapshot

Das Antagonistenprotokoll bei der ovariellen Stimulation

inferred← citeshttps://doi.org/10.1007/s00404-020-05498-2openalex-snapshot

AMH-based ovarian stimulation versus conventional ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1007/s00404-020-05954-zopenalex-snapshot

Meta-analysis of GnRH-antagonists versus GnRH-agonists in poor responder protocols

inferred← citeshttps://doi.org/10.1007/s00404-021-06351-wopenalex-snapshot

Should intrauterine inseminations still be proposed in cases of unexplained infertility? Retrospective study and literature review

inferred← citeshttps://doi.org/10.1007/s00404-022-06702-1openalex-snapshot

The influence of morphologic grading and COS protocol on the outcomes of Day 5 versus Day 6 single fresh blastocyst transfers: a retrospective analysis of clinical outcomes from one center experience

inferred← citeshttps://doi.org/10.1007/s00404-023-07285-1openalex-snapshot

Effect of GnRH agonist trigger with or without low-dose hCG on reproductive outcomes for PCOS women with freeze-all strategy: a propensity score matching study

inferred← citeshttps://doi.org/10.1007/s00404-023-07287-zopenalex-snapshot

The effects of flexible short protocol with gonadotropin-releasing hormone antagonist on preventing premature ovulation in poor responders

inferred← citeshttps://doi.org/10.1007/s00404-024-07474-6openalex-snapshot

The comparision among euploidy of preimplantation blastocysts in different controlled ovary stimulation (COH) protocols

inferred← citeshttps://doi.org/10.1007/s10304-020-00313-2openalex-snapshot

Der Platz der Gonadotropin-Releasing-Hormon-Antagonisten in der ovariellen Stimulation – immer noch eine Kontroverse?

inferred← citeshttps://doi.org/10.1007/s10815-018-1204-7openalex-snapshot

Comprehensive genetic testing for female and male infertility using next-generation sequencing

inferred← citeshttps://doi.org/10.1007/s10815-018-1264-8openalex-snapshot

The curious case of premature luteinization

inferred← citeshttps://doi.org/10.1007/s10815-018-1383-2openalex-snapshot

Testosterone therapy for women with poor ovarian response undergoing IVF: a meta-analysis of randomized controlled trials

inferred← citeshttps://doi.org/10.1007/s10815-020-02014-yopenalex-snapshot

Oxidative stress markers in the follicular fluid of patients with polycystic ovary syndrome correlate with a decrease in embryo quality

inferred← citeshttps://doi.org/10.1007/s10815-022-02557-2openalex-snapshot

The effect of ovarian stimulation on aneuploidy of early aborted tissues and preimplantation blastocysts: comparison of the GnRH agonist long protocol with the GnRH antagonist protocol

inferred← citeshttps://doi.org/10.1007/s10815-023-02790-3openalex-snapshot

Time to live birth: towards a common agreement

inferred← citeshttps://doi.org/10.1007/s10815-025-03601-7openalex-snapshot

Embryo division timings and top-quality embryo rates in GnRH-Antagonist ICSI cycles: a comparison of hCG and dual trigger methods

inferred← citeshttps://doi.org/10.1007/s10815-025-03650-yopenalex-snapshot

Impact of controlled ovarian hyperstimulation protocols on aneuploidy of preimplantation blastocysts in women aged 21–37 years old

inferred← citeshttps://doi.org/10.1007/s10815-025-03730-zopenalex-snapshot

Magnitude of Post-Retrieval Estradiol Decline Directly Compromises Clinical Pregnancy and Live Birth Rates in High Responders Undergoing IVF/ICSI cycles with antagonist protocols

inferred← citeshttps://doi.org/10.1007/s11596-022-2687-0openalex-snapshot

Clinical Application of Double Ovulation Stimulation in Patients with Diminished Ovarian Reserve and Asynchronous Follicular Development Undergoing Assisted Reproduction Technology

inferred← citeshttps://doi.org/10.1007/s12325-020-01612-7openalex-snapshot

Comparison of the Long-Acting GnRH Agonist Follicular Protocol with the GnRH Antagonist Protocol in Women Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis

inferred← citeshttps://doi.org/10.1007/s12325-023-02582-2openalex-snapshot

Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study

inferred← citeshttps://doi.org/10.1007/s13738-021-02312-xopenalex-snapshot

An overview on the two recent decades’ study of peptides synthesis and biological activities in Iran

inferred← citeshttps://doi.org/10.1007/s13738-021-02484-6openalex-snapshot

Synthesis, molecular modeling and functional evaluation of a GnRH antagonist

inferred← citeshttps://doi.org/10.1007/s40265-020-01324-wopenalex-snapshot

Current Therapeutic Options for Controlled Ovarian Stimulation in Assisted Reproductive Technology

inferred← citeshttps://doi.org/10.1007/s43032-021-00550-1openalex-snapshot

Optimal Oocyte Number in Controlled Ovarian Stimulation with Gonadotropin-Releasing Hormone Agonist/Antagonist and Day 3 Fresh Embryo Transfer

inferred← citeshttps://doi.org/10.1007/s43032-022-01026-6openalex-snapshot

GnRH Antagonist Protocol Enhances Coagulation During Controlled Ovarian Stimulation for IVF

inferred← citeshttps://doi.org/10.1016/b978-0-323-85687-4.00010-5openalex-snapshot

Maximizing fertility outcomes in poor ovarian response patients

inferred← citeshttps://doi.org/10.1016/b978-0-323-85687-4.00011-7openalex-snapshot

The GnRH antagonist protocol

inferred← citeshttps://doi.org/10.1016/b978-0-323-85687-4.00013-0openalex-snapshot

Infertility care of the PCOS patient

inferred← citeshttps://doi.org/10.1016/b978-0-323-85687-4.00027-0openalex-snapshot

The mild stimulation in vitro fertilization protocol

inferred← citeshttps://doi.org/10.1016/b978-0-323-85687-4.00035-xopenalex-snapshot

The long gonadotropin releasing hormone agonist IVF protocol

inferred← citeshttps://doi.org/10.1016/b978-0-323-89907-9.00012-0openalex-snapshot

Ovarian stimulation protocols

inferred← citeshttps://doi.org/10.1016/b978-0-443-21477-6.00245-5openalex-snapshot

Role of Agonists and Antagonists in COS

inferred← citeshttps://doi.org/10.1016/b978-0-443-21477-6.00282-0openalex-snapshot

Evaluation and ART of the Low Ovarian Responder Patient

inferred← citeshttps://doi.org/10.1016/b978-2-294-77656-4.00038-2openalex-snapshot

Syndrome d'hyperstimulation ovarienne (SHO)

inferred← citeshttps://doi.org/10.1016/b978-2-294-78134-6.00019-xopenalex-snapshot

Stimulation des patientes faibles répondeuses en FIV

inferred← citeshttps://doi.org/10.1016/j.coph.2022.102345openalex-snapshot

Recent advances in emerging PCOS therapies

inferred← citeshttps://doi.org/10.1016/j.ejogrb.2019.02.001openalex-snapshot

An AMH-based FSH dosing algorithm for OHSS risk reduction in first cycle antagonist protocol for IVF/ICSI

inferred← citeshttps://doi.org/10.1016/j.ejogrb.2020.12.024openalex-snapshot

Patients with higher anti-Müllerian hormone levels from POSEIDON group 4 benefit from GnRH-agonist long protocol: A retrospective study

inferred← citeshttps://doi.org/10.1016/j.ejogrb.2021.02.023openalex-snapshot

In vitro fertilization outcomes in women with polycystic ovary syndrome: A meta-analysis

inferred← citeshttps://doi.org/10.1016/j.ejogrb.2023.01.012openalex-snapshot

Recombinant-luteinzing hormone supplementation in women during IVF/ICSI cycles with GNRH-antagonist protocol: A systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1016/j.ejogrb.2025.01.023openalex-snapshot

Predicting the risk of a high proportion of three/multiple pronuclei (3PN/MPN) zygotes in individual IVF cycles using comparative machine learning algorithms

inferred← citeshttps://doi.org/10.1016/j.eprac.2023.09.004openalex-snapshot

Assisted Reproductive Technology in the Presence of Polycystic Ovary Syndrome: Current Evidence and Knowledge Gaps

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2018.03.006openalex-snapshot

Role of gonadotropin-releasing hormone agonists, human chorionic gonadotropin (hCG), progesterone, and estrogen in luteal phase support after hCG triggering, and when in pregnancy hormonal support can be stopped

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2018.04.037openalex-snapshot

Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2019.05.028openalex-snapshot

Assisted reproductive technology strategies in uterus transplantation

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2019.07.008openalex-snapshot

Ovarian stimulation and assisted reproductive technology outcomes in women transplanted with cryopreserved ovarian tissue: a systematic review

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2021.03.036openalex-snapshot

Impact of oral antibiotic treatment for chronic endometritis on pregnancy outcomes in the following frozen-thawed embryo transfer cycles of infertile women: a cohort study of 640 embryo transfer cycles

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2024.01.027openalex-snapshot

A randomized controlled trial to compare the live birth rate of the first frozen embryo transfer following the progestin-primed ovarian stimulation protocol vs. the antagonist protocol in women with an anticipated high ovarian response

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2024.08.340openalex-snapshot

Ovarian stimulation protocols: impact on oocyte and endometrial quality and function

inferred← citeshttps://doi.org/10.1016/j.fertnstert.2024.09.011openalex-snapshot

Programming the onset of ovarian stimulation: from early follicular phase start to oral contraceptive pill, to luteal phase E2, Duostim, and random start oral contraceptive protocols

inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e17492openalex-snapshot

Elevated follicular cortisone level is a negative predictor of clinical pregnancy in women undergoing fresh embryo transfer

inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e20016openalex-snapshot

Young obese patients may benefit from GnRH-a long protocol contributing to higher implantation rate and live birth rate of fresh IVF-ET cycles

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e35088openalex-snapshot

Hotspots and frontiers in luteal phase defect research: An in-depth global trend bibliometric and visualization analysis over a 52-year period

inferred← citeshttps://doi.org/10.1016/j.jare.2025.10.040openalex-snapshot

Artificial intelligence-driven precision treatment of reproductive medicine-related diseases: the optimal protocol choice for IVF-ET

inferred← citeshttps://doi.org/10.1016/j.jchf.2023.07.009openalex-snapshot

Cardio-Obstetrics and Heart Failure

inferred← citeshttps://doi.org/10.1016/j.jogoh.2020.101999openalex-snapshot

Impact of changing the ovarian hyperstimulation protocol in the sequental cycle on ICSI outcomes in the same patient population

inferred← citeshttps://doi.org/10.1016/j.jogoh.2024.102850openalex-snapshot

The effect of intravenous calcium gluconate on the prevention of ovarian hyperstimulation syndrome. (A randomized clinical trial)

inferred← citeshttps://doi.org/10.1016/j.jri.2021.103434openalex-snapshot

Endothelial function and concentrations of high-sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor-alpha during a long agonist IVF protocol

inferred← citeshttps://doi.org/10.1016/j.jri.2026.104894openalex-snapshot

Oncofertility pharmacovigilance in women receiving immune checkpoint inhibitors: Reproductive risks, fertility preservation, and pregnancy outcomes

inferred← citeshttps://doi.org/10.1016/j.medre.2018.04.002openalex-snapshot

Reproducción en pacientes de más de 40 años: estudio multicéntrico de los resultados obstétricos de 2.578 partos

inferred← citeshttps://doi.org/10.1016/j.medre.2019.12.001openalex-snapshot

Análisis de los indicadores de calidad entre los diferentes centros públicos españoles en técnicas de reproducción asistida; benchmarking

inferred← citeshttps://doi.org/10.1016/j.rbmo.2018.09.019openalex-snapshot

How time to healthy singleton delivery could affect decision-making during infertility treatment: a Delphi consensus

inferred← citeshttps://doi.org/10.1016/j.rbmo.2018.12.030openalex-snapshot

Pituitary suppression protocol among Bologna poor responders undergoing ovarian stimulation using corifollitropin alfa: does it play any role?

inferred← citeshttps://doi.org/10.1016/j.rbmo.2019.03.100openalex-snapshot

The effect of a GnRH antagonist on follicle maturation in normal women

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.03.005openalex-snapshot

Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.08.002openalex-snapshot

Effect of newborn gender on placental histopathology and perinatal outcome in singleton live births following IVF

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.08.035openalex-snapshot

Effect of recombinant LH supplementation on cumulative live birth rate compared with FSH alone in poor ovarian responders: a large, real-world study

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.09.001openalex-snapshot

Incidences and risk factors of moderate-to-severe ovarian hyperstimulation syndrome and severe hemoperitoneum in 1,435,108 oocyte retrievals

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.10.006openalex-snapshot

Effect of GnRH-antagonist, mifepristone and letrozole on preventing ovarian hyperstimulation syndrome in rat model

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.10.009openalex-snapshot

The relationship between a novel evaluation parameter of premature luteinization and IVF outcomes

inferred← citeshttps://doi.org/10.1016/j.rbmo.2020.11.013openalex-snapshot

The freeze-all strategy after IVF: which indications?

inferred← citeshttps://doi.org/10.1016/j.rbmo.2021.11.020openalex-snapshot

Higher exogenous gonadotrophin doses increase the risk of small for gestational age singletons after fresh embryo transfers

inferred← citeshttps://doi.org/10.1016/j.rbmo.2022.07.019openalex-snapshot

The case for mild stimulation for IVF: recommendations from The International Society for Mild Approaches in Assisted Reproduction

inferred← citeshttps://doi.org/10.1016/j.rbmo.2023.03.007openalex-snapshot

Outcomes of oocyte vitrification in trans masculine individuals

inferred← citeshttps://doi.org/10.1016/j.rbmo.2023.103767openalex-snapshot

Fertility preservation in patients undergoing gonadotoxic treatments: a Canadian Fertility and Andrology Society clinical practice guideline

inferred← citeshttps://doi.org/10.1016/j.rbmo.2026.105822openalex-snapshot

Corifollitropin alfa N02 versus recombinant FSH for ovarian stimulation: a phase 3 trial and safety study in Chinese women

inferred← citeshttps://doi.org/10.1016/j.reprotox.2022.07.006openalex-snapshot

Association between exposures to phthalate metabolites and preterm birth and spontaneous preterm birth: A systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1016/j.tem.2020.01.009openalex-snapshot

Frozen IVF Cycles to Circumvent the Hormonal Storm on Endometrium

inferred← citeshttps://doi.org/10.1016/j.tem.2023.02.002openalex-snapshot

Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome

inferred← citeshttps://doi.org/10.1016/j.tjog.2019.07.013openalex-snapshot

A novel strategy of using corifollitropin alfa in the ultrashort gonadotropin-releasing hormone agonist (GnRHa) protocol in unselected patients: A patient-friendly alternative

inferred← citeshttps://doi.org/10.1016/j.tjog.2024.01.015openalex-snapshot

Comparison of miscarriage rates in low prognosis patients according to the POSEIDON criteria

inferred← citeshttps://doi.org/10.1016/j.xfre.2021.05.001openalex-snapshot

Treatment of primary infertility in McCune-Albright syndrome: a case report of a successful in vitro fertilization cycle

inferred← citeshttps://doi.org/10.1016/j.xfre.2023.01.008openalex-snapshot

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine

inferred← citeshttps://doi.org/10.1016/j.xfre.2023.02.009openalex-snapshot

Ganirelix and the prevention of premature luteinizing hormone surges

inferred← citeshttps://doi.org/10.1016/j.xfss.2023.11.004openalex-snapshot

Transcriptomic signature of luteinized cumulus cells of oocytes developing to live birth after women received intracytoplasmic sperm injection

inferred← citeshttps://doi.org/10.1016/j.yfrne.2020.100876openalex-snapshot

Gonadotropin-releasing hormone analogs: Mechanisms of action and clinical applications in female reproduction

inferred← citeshttps://doi.org/10.1016/s0246-1064(23)47743-2openalex-snapshot

10.1016/s0246-1064(23)47743-2

inferred← citeshttps://doi.org/10.1016/s1773-035x(18)30212-0openalex-snapshot

Assistance médicale à la procréation : techniques actuelles et nouveaux horizons

inferred← citeshttps://doi.org/10.1017/9781108582322.018openalex-snapshot

Assisted Conception Techniques

inferred← citeshttps://doi.org/10.1017/9781108582322.019openalex-snapshot

Ovarian Hyperstimulation Syndrome

inferred← citeshttps://doi.org/10.1017/9781108986373.085openalex-snapshot

Pituitary Suppression Using GnRH Agonist for IVF Is Outdated

inferred← citeshttps://doi.org/10.1017/9781108986373.086openalex-snapshot

Pituitary Suppression Using GnRH Agonist for IVF Is Outdated

inferred← citeshttps://doi.org/10.1017/9781316477021.009openalex-snapshot

GnRH Agonists for Ovarian Hyperstimulation

inferred← citeshttps://doi.org/10.1017/9781316477021.010openalex-snapshot

Role of GnRH Antagonist in Assisted Reproduction

inferred← citeshttps://doi.org/10.1017/9781316477021.015openalex-snapshot

Ovarian Stimulation in Difficult IVF Cases

inferred← citeshttps://doi.org/10.1017/9781316477021.017openalex-snapshot

Polycystic Ovary Syndrome: Controlled Ovarian Stimulation

inferred← citeshttps://doi.org/10.1017/9781316477021.018openalex-snapshot

Prevention of Ovarian Hyperstimulation Syndrome

inferred← citeshttps://doi.org/10.1017/9781316477021.019openalex-snapshot

Treatment of Ovarian Hyperstimulation Syndrome

inferred← citeshttps://doi.org/10.1017/9781316477021.020openalex-snapshot

How to Individualize Ovarian Stimulation Protocols to Avoid Difficulties and Complications

inferred← citeshttps://doi.org/10.1017/9781316477021.023openalex-snapshot

Adjuncts for Ovarian Stimulation

inferred← citeshttps://doi.org/10.1017/erm.2023.25openalex-snapshot

Live birth rate of gonadotropin-releasing hormone antagonist versus luteal phase gonadotropin-releasing hormone agonist protocol in IVF/ICSI: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1021/acsnano.5c00918openalex-snapshot

Polyethylene and Polyvinyl Chloride Nanoplastics in Human Follicular Fluid and Seminal Plasma: Impact on Fertilization and Sperm Quality

inferred← citeshttps://doi.org/10.1038/s41467-022-30581-4openalex-snapshot

Targeting dual-specificity tyrosine phosphorylation-regulated kinase 2 with a highly selective inhibitor for the treatment of prostate cancer

inferred← citeshttps://doi.org/10.1038/s41591-026-04585-2openalex-snapshot

Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations

inferred← citeshttps://doi.org/10.1038/s41598-020-65558-0openalex-snapshot

Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization

inferred← citeshttps://doi.org/10.1038/s41598-021-02227-wopenalex-snapshot

Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol

inferred← citeshttps://doi.org/10.1038/s41598-022-08400-zopenalex-snapshot

Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1038/s41598-022-22859-wopenalex-snapshot

Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria

inferred← citeshttps://doi.org/10.1038/s41598-024-64804-zopenalex-snapshot

Comparison of luteal support protocols in fresh IVF/ICSI cycles: a network meta-analysis

inferred← citeshttps://doi.org/10.1038/s41598-024-82630-1openalex-snapshot

Intraovarian platelet-rich plasma injection significantly improves blastocyst yield and quality in IVF patients

inferred← citeshttps://doi.org/10.1038/s41598-025-24192-4openalex-snapshot

Progestin primed ovarian stimulation yields comparable outcomes to the GnRH antagonist protocol for controlled ovarian hyperstimulation

inferred← citeshttps://doi.org/10.1055/s-0041-1736492openalex-snapshot

Ovarian Hyperstimulation: Diagnosis, Prevention, and Management

inferred← citeshttps://doi.org/10.1080/01443615.2024.2346228openalex-snapshot

Prolidase activity in women with polycystic ovarian syndrome undergoing assisted conception

inferred← citeshttps://doi.org/10.1080/09513590.2019.1650345openalex-snapshot

Decision points for individualized hormonal stimulation with recombinant gonadotropins for treatment of women with infertility

inferred← citeshttps://doi.org/10.1080/09513590.2020.1770214openalex-snapshot

How fixed versus variable gonadotropin dose during controlled ovarian stimulation could influence the management of infertility patients undergoing IVF treatment: a national Delphi consensus

inferred← citeshttps://doi.org/10.1080/09513590.2021.1952976openalex-snapshot

HOMA-IR for predicting clinical pregnancy rate during IVF

inferred← citeshttps://doi.org/10.1080/09513590.2021.1955341openalex-snapshot

Effects of increasing serum luteinizing hormone levels during early phase of the gonadotropin-releasing hormone antagonist protocol on clinical outcomes of the in vitro fertilization cycle

inferred← citeshttps://doi.org/10.1080/09513590.2022.2154339openalex-snapshot

Antral follicle count measured at down-regulation as predictor of ovarian response and cumulative live birth: single center analysis including 2731 long agonist IVF cycles

inferred← citeshttps://doi.org/10.1080/09513590.2023.2269281openalex-snapshot

Cocktail treatment by GnRH-antagonist, letrozole, and mifepristone for the prevention of ovarian hyperstimulation syndrome: a prospective randomized trial

inferred← citeshttps://doi.org/10.1080/09513590.2024.2421487openalex-snapshot

GnRH antagonist impairs the process of embryo implantation by inhibiting motility of endometrial stromal cells through reducing c-kit expression

inferred← citeshttps://doi.org/10.1080/13102818.2021.2022993openalex-snapshot

Cost-effectiveness of in vitro fertilization and controlled ovarian hyperstimulation before and after the COVID-19 outbreak

inferred← citeshttps://doi.org/10.1080/14647273.2023.2175267openalex-snapshot

Comparison of the efficacy of depot GnRH agonist protocol and the GnRH antagonist protocol in patients with repeated IVF failure: a retrospective cohort study

inferred← citeshttps://doi.org/10.1080/14647273.2024.2352387openalex-snapshot

Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and prevention

inferred← citeshttps://doi.org/10.1080/14647273.2024.2441827openalex-snapshot

Prevention of ovarian hyperstimulation syndrome (OHSS): British Fertility Society policy and practice guideline

inferred← citeshttps://doi.org/10.1080/14656566.2024.2418985openalex-snapshot

Recent developments in drug treatment strategies for infertility in patients with polycystic ovary syndrome

inferred← citeshttps://doi.org/10.1080/19396368.2025.2564146openalex-snapshot

Comparative assisted reproductive technologies in human and veterinary medicine: implications for reproductive success

inferred← citeshttps://doi.org/10.1093/hropen/hoaa009openalex-snapshot

ESHRE guideline: ovarian stimulation for IVF/ICSI†

inferred← citeshttps://doi.org/10.1093/hropen/hoab022openalex-snapshot

The Maribor consensus: report of an expert meeting on the development of performance indicators for clinical practice in ART

inferred← citeshttps://doi.org/10.1093/hropen/hoag042openalex-snapshot

Effect of vaginal estrogen supplementation for luteal phase support in the GnRH antagonist protocol on pregnancy outcomes for IVF/ICSI cycles: a randomized controlled trial

inferred← citeshttps://doi.org/10.1093/humrep/deaa086openalex-snapshot

The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study

inferred← citeshttps://doi.org/10.1093/humrep/deab065openalex-snapshot

Reduced FSH and LH action: implications for medically assisted reproduction

inferred← citeshttps://doi.org/10.1093/humrep/deac040openalex-snapshot

Associations of sleep characteristics with outcomes of IVF/ICSI treatment: a prospective cohort study

inferred← citeshttps://doi.org/10.1093/humrep/deac081openalex-snapshot

Estrogen valerate pretreatment with the antagonist protocol does not increase oocyte retrieval in patients with low ovarian response: a randomized controlled trial

inferred← citeshttps://doi.org/10.1093/humrep/deac167openalex-snapshot

The impact of embryo vitrification on placental histopathology features and perinatal outcome in singleton live births

inferred← citeshttps://doi.org/10.1093/humrep/deac171openalex-snapshot

Embryologist agreement when assessing blastocyst implantation probability: is data-driven prediction the solution to embryo assessment subjectivity?

inferred← citeshttps://doi.org/10.1093/humrep/deae092openalex-snapshot

BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle

inferred← citeshttps://doi.org/10.1093/humrep/deae145openalex-snapshot

A modified flexible GnRH antagonist protocol using antagonist early cessation and a gonadotropin step-down approach improves live birth rates in fresh cycles: a randomized controlled trial

inferred← citeshttps://doi.org/10.1093/humrep/deaf082openalex-snapshot

SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial

inferred← citeshttps://doi.org/10.1093/humrep/dey119openalex-snapshot

Increased AIF-1-mediated TNF-α expression during implantation phase in IVF cycles with GnRH antagonist protocol

inferred← citeshttps://doi.org/10.1093/humrep/dey382openalex-snapshot

Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response

inferred← citeshttps://doi.org/10.1093/humrep/dez233openalex-snapshot

Should we still perform fresh embryo transfers in ART?

inferred← citeshttps://doi.org/10.1093/humupd/dmaa040openalex-snapshot

Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses

inferred← citeshttps://doi.org/10.1093/humupd/dmac028openalex-snapshot

Administration of growth hormone improves endometrial function in women undergoing in vitro fertilization: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1093/humupd/dmx037openalex-snapshot

GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions

inferred← citeshttps://doi.org/10.1093/humupd/dmx038openalex-snapshot

Reply: GnRH antagonists vs. long GnRH agonists in IVF: significant flaws in a meta-analysis lead to invalid conclusions

inferred← citeshttps://doi.org/10.1093/humupd/dmz037openalex-snapshot

Ovarian stimulation for freeze-all IVF cycles: a systematic review

inferred← citeshttps://doi.org/10.1093/molehr/gaz033openalex-snapshot

Successful reversal of ovarian hyperstimulation syndrome in a mouse model by rapamycin, an mTOR pathway inhibitor

inferred← citeshttps://doi.org/10.1097/cm9.0000000000000246openalex-snapshot

Role of the proportion of dominant follicles in patients with polycystic ovary syndrome undergoing in vitro fertilization-embryo transfer

inferred← citeshttps://doi.org/10.1097/cm9.0000000000002370openalex-snapshot

A propensity score matching comparison between GnRH agonist and GnRH antagonist protocols in patients in POSEIDON groups 3 and 4

inferred← citeshttps://doi.org/10.1097/grf.0000000000000436openalex-snapshot

Anti-Müllerian Hormone and Its Predictive Utility in Assisted Reproductive Technologies Outcomes

inferred← citeshttps://doi.org/10.1097/grf.0000000000000561openalex-snapshot

In Vitro Fertilization for Polycystic Ovarian Syndrome

inferred← citeshttps://doi.org/10.1097/grh.0000000000000113openalex-snapshot

Evidence-based recommendations for managing poor ovarian response

inferred← citeshttps://doi.org/10.1097/md.0000000000047609openalex-snapshot

Clinical outcomes of long follicular-phase protocol in first-cycle patients with diminished ovarian reserve and AMH<1.2 ng/mL: A single-center study

inferred← citeshttps://doi.org/10.1097/rd9.0000000000000070openalex-snapshot

Effects of changing the control ovarian stimulation protocol in patients without a transplantable embryo in the previous in vitro fertilization/intracytoplasmic sperm injection cycle

inferred← citeshttps://doi.org/10.1101/2024.06.28.24309669openalex-snapshot

The effect of artificial oocyte activation on blastocysts rate in patients with low blastocyst rates: A retrospective cohort study

inferred← citeshttps://doi.org/10.1101/2024.10.11.24315288openalex-snapshot

WITHDRAWN: Prednisone enhances pregnancy outcomes in gonadotropin-releasing hormone antagonist protocol: a multi-center randomized clinical trial

inferred← citeshttps://doi.org/10.1111/1471-0528.16461openalex-snapshot

Pregnancy outcome and cost‐effectiveness comparisons of artificial cycle‐prepared frozen embryo transfer with or without GnRH agonist pretreatment for polycystic ovary syndrome: a randomised controlled trial

inferred← citeshttps://doi.org/10.1111/ajo.13051openalex-snapshot

A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome

inferred← citeshttps://doi.org/10.1111/aogs.13664openalex-snapshot

Do female age and body weight modify the effect of individualized FSH dosing in IVF / ICSI treatment? A secondary analysis of the OPTIMIST trial

inferred← citeshttps://doi.org/10.1111/jog.16065openalex-snapshot

Luteinizing hormone supplementation with human menopausal gonadotropin versus low dose human chorionic gonadotropin during ovarian stimulation does not affect live birth rates after fresh and frozen embryo transfer

inferred← citeshttps://doi.org/10.1111/tog.12975openalex-snapshot

Ovarian hyperstimulation syndrome – risk reduction strategies

inferred← citeshttps://doi.org/10.1136/bmjopen-2020-038153openalex-snapshot

Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial

inferred← citeshttps://doi.org/10.1136/bmjopen-2020-039122openalex-snapshot

Controlled ovarian hyperstimulation for poor ovarian responders undergoing in vitro fertilisation/intracytoplasmic sperm injection: a protocol for systematic review and Bayesian network meta-analysis

inferred← citeshttps://doi.org/10.1142/s2661318226300023openalex-snapshot

Genetic and Molecular Etiologies of Male Infertility: Advances in Diagnosis and Clinical Implications

inferred← citeshttps://doi.org/10.11603/1681-2786.2018.4.10036openalex-snapshot

ПОРІВНЯЛЬНА ХАРАКТЕРИСТИКА ПРОТОКОЛІВ СТИМУЛЯЦІЇ ОВУЛЯЦІЇ З ВИКОРИСТАННЯМ АГОНІСТІВ ТА АНТАГОНІСТІВ ГОНАДОТРОПІН-РИЛІЗИНГ-ГОРМОНІВ У ПРОГРАМАХ ДОПОМІЖНИХ РЕПРОДУКТИВНИХ ТЕХНОЛОГІЙ (ОГЛЯД ЛІТЕРАТУРИ)

inferred← citeshttps://doi.org/10.1177/03000605211016161openalex-snapshot

Factors affecting the accuracy and reliability of the measurement of anti-Müllerian hormone concentration in the clinic

inferred← citeshttps://doi.org/10.1177/20420188231173325openalex-snapshot

Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review

inferred← citeshttps://doi.org/10.1177/2633494120941480openalex-snapshot

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept

inferred← citeshttps://doi.org/10.1177/26334941221147464openalex-snapshot

Treatment modalities for poor ovarian responders

inferred← citeshttps://doi.org/10.1186/s12884-021-03698-5openalex-snapshot

Fertility outcomes in women after controlled ovarian stimulation with gonadotropin releasing hormone agonist long protocol: fresh versus frozen embryo transfer

inferred← citeshttps://doi.org/10.1186/s12884-021-03833-2openalex-snapshot

Fixed versus flexible antagonist protocol in women with predicted high ovarian response except PCOS: a randomized controlled trial

showing the first 200 of 405

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.